Source: Abstracts. Conference titles: European Cancer Congress. Unidade: FMRP
Subjects: NEOPLASIAS DO COLON, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, K. B. et al. CHK2 expression as predictor factor of tumor aggressiveness and shorter survival in metastatic colon cancer patients. 2013, Anais.. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. . Acesso em: 10 jan. 2026.APA
Ribeiro, K. B., Silva, A. F., Garcia, S. B., Feres, O., Rocha, J. J. R. da, Zanetti, J. S., & Peria, F. M. (2013). CHK2 expression as predictor factor of tumor aggressiveness and shorter survival in metastatic colon cancer patients. In Abstracts. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Ribeiro KB, Silva AF, Garcia SB, Feres O, Rocha JJR da, Zanetti JS, Peria FM. CHK2 expression as predictor factor of tumor aggressiveness and shorter survival in metastatic colon cancer patients. Abstracts. 2013 ;[citado 2026 jan. 10 ]Vancouver
Ribeiro KB, Silva AF, Garcia SB, Feres O, Rocha JJR da, Zanetti JS, Peria FM. CHK2 expression as predictor factor of tumor aggressiveness and shorter survival in metastatic colon cancer patients. Abstracts. 2013 ;[citado 2026 jan. 10 ]
